Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors

被引:10
|
作者
Zhou, Xuan [1 ]
Zhang, Xueyan [1 ]
Zhong, Tangsheng [1 ]
Zhou, Meng [1 ]
Gao, Lan [2 ,4 ]
Chen, Li [1 ,3 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Changchun, Peoples R China
[3] Jilin Univ, Sch Nursing, 965 Xinjiang St, Changchun 130021, Jilin, Peoples R China
[4] First Hosp Jilin Univ, 71 Xinmin St, Changchun 130031, Jilin, Peoples R China
关键词
breast cancer; chemotherapy-related cognitive impairment; nursing; systematic review; older adults; CHEMOBRAIN; ADULTS; AGE;
D O I
10.1111/jan.15842
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
AimsTo examine the prevalence and associated factors of chemotherapy-related cognitive impairment (CRCI) in older breast cancer survivors (BCS).DesignSystematic review.Data SourcesWe searched EMBASE, PubMed, PsychInfo, CINAHL, Cochrance Library, Web of Science, CNKI and SinoMed, without language restrictions, for studies published from the establishment of the database to September 2022.Review MethodsTwo researchers independently examined the full texts, data extraction and quality assessment, and any discrepancies were resolved through discussion with a third reviewer. Quality of evidence was assessed using the Newcastle-Ottawa Scale and the Agency for Healthcare Research and Quality Scale.ResultsThe seven included studies showed that the estimated prevalence of CRCI in older BCS ranged from 18.6% to 27% on objective neuropsychological tests and from 7.6% to 49% on subjective cognitive assessments. The areas most affected were attention, memory, executive functioning and processing speed. CRCI was associated with 10 factors in six categories, including sociodemographic (e.g. age, education level), physiological (e.g. sleep disorders, fatigue and comorbidities), psychological (e.g. anxiety, depression), treatment modalities (e.g. chemotherapy cycles, chemotherapy regimens), genetic (e.g. APOE2, APOE4) and lifestyle factor (e.g. physical inactivity).ConclusionCRCI is multifactorial and has a relatively high prevalence. However, the results of subjective and objective cognitive examinations were inconsistent, possibly due to variations in tools used to evaluate different definitions of CRCI. Nevertheless, as there are few published studies of older BCS, this conclusion still require verification by well-designed studies in the future.ImpactWe found that the prevalence of CRCI in older adults is relatively high and multifactorial, providing evidence for further health care for this population.No Patient or Public ContributionThere was no patient or public involvement.
引用
收藏
页码:484 / 499
页数:16
相关论文
共 50 条
  • [31] Functional connectome biotypes of chemotherapy-related cognitive impairment
    Shelli R. Kesler
    Melissa L. Petersen
    Vikram Rao
    Rebecca A. Harrison
    Oxana Palesh
    Journal of Cancer Survivorship, 2020, 14 : 483 - 493
  • [32] The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2-/+ Breast Cancer
    Li, Wen
    Zhang, Qianqian
    Cai, Yinlian
    Chen, Tingting
    Cheng, Huaidong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Therapies for cognitive impairment in breast cancer survivors treated with chemotherapy A protocol for systematic review
    Zhang, Qiuhua
    Gao, Xiufei
    Liu, Shan
    Yu, Linghong
    Zhu, Jiayan
    Qiu, Shengliang
    MEDICINE, 2020, 99 (19) : E20092
  • [34] Use of focused computerized cognitive training (Neuroflex) to improve symptoms in women with persistent chemotherapy-related cognitive impairment
    Vega, Jennifer N.
    Newhouse, Paul A.
    Conley, Alexander C.
    Szymkowicz, Sarah M.
    Gong, Xuewen
    Cote, Sarah
    Mayer, Ingrid
    Taylor, Warren D.
    Morimoto, Sarah Shizuko
    DIGITAL HEALTH, 2023, 9
  • [35] Long-term changes of cognitive impairment among older breast cancer survivors
    Luo, Juhua
    Schousboe, John T.
    Ensrud, Kristine E.
    Hendryx, Michael
    JOURNAL OF CANCER SURVIVORSHIP, 2023, 17 (06) : 1760 - 1768
  • [36] Chemotherapy-related cognitive impairment or << chemobrain >> : concept and state of art
    Bompaire, Flavie
    Durand, Thomas
    Leger-Hardy, Isabelle
    Psimaras, Dimitri
    Ricard, Damien
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2017, 15 (01): : 89 - 98
  • [37] Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause
    Vega, Jennifer N.
    Dumas, Julie
    Newhouse, Paul A.
    PSYCHO-ONCOLOGY, 2018, 27 (09) : 2198 - 2205
  • [38] Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021
    Amani, Omid
    Mazaheri, Mohammad Ali
    Moghani, Mona Malekzadeh
    Zarani, Fariba
    Choolabi, Rasool Hamidi
    CANCER REPORTS, 2024, 7 (02)
  • [39] Adjuvant Chemotherapy for Breast Cancer and Cognitive Impairment
    Pinto Marin, Alvaro
    Redondo Sanchez, Andres
    Espinosa Arranz, Enrique
    Zamora Aunon, Pilar
    Gonzalez Baron, Manuel
    SOUTHERN MEDICAL JOURNAL, 2009, 102 (09) : 929 - 934
  • [40] Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer
    Yao, Senbang
    Zhang, Qianqian
    Yao, Xinxin
    Zhang, Xiuqing
    Pang, Lulian
    Yu, Sheng
    Cheng, Huaidong
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (01) : 15 - 26